The Incidence Rate of Breast Cancer in Suleimani Governorate in 2006: Preliminary Study


  • Ali Hattem Hussein Foundation of Technical Education, Kurdistan Region, Iraq. Author
  • Peri Mohammad Aziz Foundation of Technical Education, Kurdistan Region, Iraq. Author



Breast cancer, Suleimani city, Incidence rate, 2006, Mammography, Risk factors


Background: Breast cancer is the most common site-specific cancer in women. The incidence rate of breast cancer in Suleimani did not estimated before the year 2006. The aim of this study is to find out the incidence rate of breast cancer and some other statistical data in Suleimani city / Iraq in 2006. Patients and Methods: A questionnaire was designated to collect data from all newly diagnosed breast cancer   patients in the year 2006, and from control group. We set up a hypothesis that to be tested using Chi- Square test at 95% confidence level. Results: The number of patients was 61 (60 females and 1 male).   The incidence rate in females is 10.1 per 100000 adult females in the year 2006. The age group of highest incidence is 45 – 54. Most of patients are house wives, married, fertile, living in city center and urban areas, have no family histories of breast carcinoma, nonsmokers, have history of breast feeding, have body mass index above normal range, and mammography or U/S was infrequent screening test for breast mass done for them. Invasive ductal carcinoma of breast is the most frequent tumor among patients. The results revealed that 11 (18.0%) of patients have history of exposure to chemical weapons in the year 1988. Conclusion: The incidence rate of breast cancer in Suleimani is 10.1 per 100000 adult females in the year 2006, which is relatively low incidence.


Stewart B. W. and Kleihues P. World Cancer Report. IARCPress. 2003, Lyon.

Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and

ovarian cancer susceptibility gene BRCA1. Science. 1994; 266 (5182): 66-71. DOI:

Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin

on breast cancer and mammography in healthy postmenopausal women: the

Women's Health Initiative Randomized Trial. JAMA. 2003; 289: 3243-3253. DOI:

Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of

developing breast cancer for white females who are being examined annually.

Journal of the National Cancer Institute. 1989; 81(24): 1879-1886. DOI:

Fisher B, Osborne CK, Margolese R, et al. Neoplasms of the breast. In: Holland JF,

Frei E, Bast RC, et al., Eds.: Cancer Medicine. Philadelphia: Lea & Febiger, 3rd

ed., 1993:1706-1716.

McDivitt RW. Breast. In: Kissane JM: Anderson's pathology, ninth edition. C.V.

Mosby Company, St. Louis, Missouri. 1990; 344-369.

Kolb E. Comparison of the Performance of Screening Mammography, Physical

exam. and Breast US in Detection of Breast Cancer. Radiology, 2000: 165-175.

Ferlay J, Bray F, Pisani P, et al. Cancer Incidence, Mortality and Prevalence

Worldwide. IARC Cancer Base No. 5, 2004: version 2.0. IARC Press, Lyon.

Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the

Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1988;


James T B, Margaret M K, Kevin M G. Occupation and breast cancer: a Canadian

case-control study. Ann. N. Y. Acad. Sci. 2006; 1076: 765-777. DOI:

Nicholas P, Julia S. Presentation: Radiological Society of North America annual

meeting, Chicago. 2007; Nov. 26.

Albreksten G, Heuch I, Kvale G. The short and long term effect of a pregnancy on

breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br.

J. Cancer. 1995; 72:480-4. DOI:

Mandana E, Mariam V, Ali M. Risk factors for breast cancer in Iran: a case-

control study. Breast Cancer Res.2002; 4(5): R10.

Ambrosone CB, Kropp S, Yang J, et al. Cigarette smoking, N-acetyltransferase 2

genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer

Epidemiol Biomarkers Prev. 2008; 17(1):15-26. DOI:

Kathleen C. Smoking and risk of breast cancer in carriers of mutations in BRCA1

or BRCA2 aged less than 50 years. Breast Cancer Res. Treat. 2007; 120(1): 18-

Perkins CI, Morris CR, Wright WE, Young JL. Cancer Incidence and Mortality in

California by Detailed Race/Ethnicity, 1988-1992. Sacramento, CA: California

Department of Health Services, Cancer Surveillance Section, 1995.

Harirchi I, Ebrahimi M, Zamani N, et al. Breast cancer in Iran: a review of 903

case records. Public Health. Iranian Center for Breast Cancer (ICBC), Tehran,

Iran. 2000; 114 (2):143-5. DOI:

Perkins CI, Hotes J, Kohler BA, Howe HL. Association between breast cancer

laterality and tumor location, United States, 1994-1998. Cancer Causes Control.

; 15(7):637-45.

Blair, Hansen Am., et al. Chemical exposure in the workplace associated with

some evidence of a higher breast cancer risk. Int. J. Epidemiol. 1999; Volume 36,


Furberg AS, Veierød MB, Wilsgaard T, et al. Serum high-density lipoprotein

cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004; 96 DOI:


Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and

overweight), lifestyle (high energy intake and physical inactivity) and endometrial

cancer risk in a Norwegian cohort. Int J Cancer. 2003; 10, 104 (6):799. DOI:



How to Cite

The Incidence Rate of Breast Cancer in Suleimani Governorate in 2006: Preliminary Study. (2008). Journal of Zankoy Sulaimani - Part A, 12(1), 59-65.